pandem
consum
signific
health
care
resourc
given
concern
rapidli
rise
infect
rate
us
impend
staf
shortag
potenti
resourc
realloc
rapidli
reevalu
rectal
cancer
practic
polic
public
health
emerg
previou
pandem
commonli
util
total
neoadjuv
therapi
tnt
strong
prefer
long
cours
chemoradi
lccrt
set
ongo
pandem
mandat
short
cours
radiat
therapi
scrt
despit
multipl
random
trial
demonstr
differ
locoregion
recurr
distant
recurr
overal
surviv
scrt
lrcct
adapt
scrt
unit
state
low
given
concern
less
tumor
downstag
increas
toxic
set
ongo
like
prolong
pandem
feel
concern
must
reevalu
scrt
present
wellvalid
altern
allow
us
meet
need
greater
number
potenti
curabl
patient
time
resourc
sever
acut
constrain
earli
report
china
suggest
cancer
patient
diagnos
coronaviru
diseas
increas
need
intens
care
unit
admiss
ventil
use
higher
mortal
compar
noncanc
patient
risk
sever
complic
even
greater
cancer
patient
underw
surgeri
receiv
cytotox
chemotherapi
within
one
month
document
sever
acut
respiratori
syndrom
coronaviru
infect
robust
predictor
outcom
still
determin
seem
like
patient
undergo
activ
oncolog
therapi
elev
risk
morbid
mortal
pandem
consum
signific
health
care
resourc
even
conserv
estim
forecast
health
need
greatli
exceed
capac
unit
state
us
health
care
system
develop
countri
given
legitim
concern
impend
staf
shortag
resourc
realloc
rapidli
rise
infect
rate
us
rapidli
reevalu
rectal
cancer
practic
polic
public
health
emerg
multidisciplinari
rectal
cancer
expert
highvolum
comprehens
cancer
center
work
togeth
electron
due
need
socialphys
distanc
establish
new
institut
guidelin
rectal
cancer
treatment
pandem
prior
march
standard
approach
patient
local
advanc
rectal
cancer
favor
total
neoadjuv
therapi
tnt
incorpor
preoper
longcours
chemoradi
chemoradi
deliv
fraction
use
either
threedimension
conform
radiotherapi
intens
modul
radiat
therapi
imrt
concurr
capecitabin
sequenc
chemoradi
chemotherapi
vari
depend
clinic
scenario
induct
chemotherapi
follow
consolid
chemoradi
common
approach
given
pandem
condit
util
longcours
chemoradi
lccrt
question
given
concern
increas
infect
rate
among
patient
staff
increas
risk
infect
prolong
frequent
visit
conting
plan
realloc
institut
resourc
requir
abil
preoper
radiat
therapi
prevent
locoregion
recurr
local
advanc
rectal
cancer
wellestablish
shortcours
radiat
therapi
scrt
lccrt
scrt
shown
noninferior
altern
lccrt
multipl
random
trial
demonstr
differ
locoregion
recurr
distant
recurr
overal
surviv
scrt
deliv
fraction
use
either
imrt
protect
adjac
normal
tissu
importantli
given
higher
dose
per
fraction
concurr
chemotherapi
use
scrt
concern
express
absenc
random
data
scrt
may
result
less
tumor
downstag
especi
patient
low
rectal
tumor
ie
anal
verg
bulki
tumor
close
involv
circumferenti
resect
margin
higher
rate
late
toxic
especi
among
patient
tumor
abut
anal
canal
howev
stockholm
iii
trial
evalu
scrt
immedi
surgeri
scrt
follow
delay
surgeri
lccrt
delay
surgeri
found
differ
locoregion
recurr
distant
metastasi
overal
surviv
scrt
delay
surgeri
compar
scrt
immedi
surgeri
result
greater
tumor
downstag
higher
acut
toxic
decreas
surgic
postop
complic
longer
interv
radiat
surgeri
result
greater
tumor
downstag
scrt
lccrt
furthermor
incorpor
scrt
tnt
evalu
promis
result
still
activ
investig
colorect
diseas
manag
team
conclud
reason
necessari
deliv
tnt
scrt
offtrial
given
ongo
pandem
admittedli
potenti
differ
scrt
lccrt
yet
fulli
understood
exampl
context
nonop
manag
longterm
anal
sphincter
function
set
ongo
pandem
scrt
potenti
provid
effici
qualiti
oncolog
care
patient
significantli
decreas
patient
exposur
repeat
radiat
therapi
appoint
lccrt
decreas
likelihood
patient
diagnos
treatment
decreas
immunosuppress
omit
concurr
chemotherapi
decreas
resourc
util
set
radiotherapi
capac
may
sharpli
curtail
andor
realloc
provid
least
partial
therapi
event
surgeri
andor
chemotherapi
need
delay
reinforc
feder
state
citi
mandat
encourag
social
physic
distanc
still
address
activ
cancer
patient
care
consider
risk
benefit
mandat
hospit
name
redact
submiss
current
epidem
pass
local
advanc
rectal
cancer
patient
treat
scrt
mandat
benefit
patient
reduc
number
exposur
potenti
infect
patient
health
care
worker
lower
chanc
treatment
would
interrupt
termin
diagnos
mandat
also
best
interest
patient
popul
whole
given
decreas
util
healthcar
resourc
allow
us
treat
patient
instead
set
expect
substanti
reduct
avail
staff
administ
treatment
due
expect
staff
ill
epidem
despit
shown
cost
effect
lccrt
scrt
use
less
patient
get
neoadjuv
radiat
rectal
cancer
us
due
part
strong
physician
bias
regard
diminish
downstag
increas
toxic
set
ongo
like
prolong
pandem
feel
concern
must
reevalu
scrt
present
wellvalid
altern
shown
random
studi
result
noninferior
oncolog
outcom
rectal
cancer
radiat
uniqu
present
two
wellestablish
substanti
equival
option
local
advanc
diseas
pandem
condit
scrt
import
nononcolog
benefit
justifi
make
standard
regimen
local
advanc
rectal
cancer
name
limit
potenti
rectal
cancer
patient
contract
significantli
reduc
util
healthcar
resourc
therebi
allow
us
meet
need
greater
number
potenti
curabl
patient
time
resourc
sever
acut
constrain
